Social network you want to login/join with:
Founded in 2000, Baccinex SA, headquartered in Courroux, is part of the Adragos Pharma group. The Adragos Pharma group aims to become a leading global player in the CDMO sector.
The Courroux site is a multifunctional facility with more than 100 employees. Recognized as a European leader in the manufacture of clinical pharmaceuticals, our business is experiencing strong growth. This momentum is driving the expansion of the site as well as the development of our activities. To support us in meeting these challenges, we are looking to recruit a:
Reporting directly to the site director and the group’s finance department, you will oversee the accounting department and controlling of Adragos Jura. Responsibilities include managing accounting operations, reporting, budget forecasts, and treasury management. You will also supervise the IT department and participate in the local management committee to help lead the company to success.
If you seek new challenges in the financial sector, please contact us. We look forward to discussing opportunities with you.
Apply via our online form. We thank all applicants for their interest; only those selected for interviews will be contacted.
Adragos Pharma is a reliable Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, Germany. We provide comprehensive development and manufacturing services for drug products, including sterile and non-sterile liquids, solids, and semi-solids. Our expertise extends to biologicals, orphan drugs, clinical trials, fill-and-finish, and lyophilization, offering end-to-end solutions from development to commercial supply.
With production sites across Germany, France, Greece, Norway, Japan, and Switzerland, we ensure high-quality manufacturing throughout the drug development process. Founded in 2020 and supported by FSN Capital, Adragos Pharma has grown rapidly through an ambitious buy & build strategy. Our team of over 900 professionals is expanding across Europe, North America, and Japan to become a global leader in the CDMO sector.
As a key player in the pharmaceutical industry, CDMOs like Adragos produce 25% of all drugs globally, ensuring access to essential medications. With increasing healthcare demands, we continue to innovate and set new standards in drug manufacturing. If you want to be part of our dynamic growth, apply now!